Mounjaro (tirzepatide) has become one of the most in-demand injectable medications for type 2 diabetes and medical weight loss. With its growing popularity — especially after FDA approvals for obesity treatment — the Mounjaro 2.5 mg starter dose continues to face intermittent supply shortages across many countries.

If you or someone you know is starting Mounjaro, understanding the current shortage situation, why 2.5 mg stock is limited, and how to improve your chances of securing your dose is essential. This guide provides the latest 2025 update on availability, pharmacy stock patterns, and practical tips for patients navigating the shortage.

1. Why the Mounjaro 2.5 mg Starter Dose Keeps Running Out

The 2.5 mg dose is the first step in the titration schedule for both diabetes and weight loss treatment. Because of this, demand for this dose is significantly higher than any other strength.

1.1. Surge in Demand After Weight Loss Approval

Since regulatory bodies approved tirzepatide for chronic weight management, prescription numbers nearly doubled. Most new patients begin with 2.5 mg, putting pressure on manufacturers.

1.2. Manufacturing Bottlenecks

While higher doses (5 mg, 7.5 mg, 10 mg) may remain available, the starter dose often experiences:

  • Slower production cycles

  • Packaging limitations

  • Injector pen component shortages

  • Demand outpacing planned manufacturing volume

1.3. High Number of New Prescriptions

Doctors increasingly prescribe Mounjaro for:

  • Type 2 diabetes

  • Prediabetes

  • PCOS-related weight gain

  • Injectables for medical obesity treatment

This large number of new starts strains supply of the starting dose.

1.4. Off-Label Use Increases Demand

Even in regions where it is not officially approved for obesity, physicians often prescribe it off-label. This further amplifies demand.

2. 2025 Availability Update: What Pharmacies Are Reporting

Pharmacy stock patterns vary by region, but several common trends have emerged across 2025.

2.1. Big Chain Pharmacies Still Facing Backorders

Pharmacies like:

  • CVS

  • Walgreens

  • Boots

  • Walmart

  • Rite Aid

continue to report intermittent or prolonged backorders for Mounjaro 2.5 mg pens.

2.2. Higher Doses Often Available

In many regions:

  • 5 mg, 7.5 mg, and 10 mg appear more consistently in stock

  • But patients cannot skip directly to these doses due to titration requirements

So while higher strengths may sit on shelves, the initial dose is the main bottleneck.

2.3. Specialty Pharmacies Showing Better Stock

Some smaller specialty pharmacies have:

  • Faster resupply cycles

  • Direct manufacturer partnerships

  • Priority stock allocation

These pharmacies occasionally have the 2.5 mg dose even when major chains do not.

2.4. Regional Availability Differences

Patients in urban areas often face:

  • Longer wait lists

  • Higher prescription quantities

  • More backorder delays

Rural or suburban pharmacies may receive stock more consistently.

2.5. International Patients Report Similar Shortages

Countries like:

  • Canada

  • United Kingdom

  • Australia

  • UAE

show similar trends, confirming this is a global-level shortage.

3. How Long Will the 2.5 mg Shortage Last?

Eli Lilly has already announced increased investment in:

  • Additional manufacturing plants

  • Expanded injector pen production

  • Specialized assembly lines for tirzepatide

The company has estimated supply improvements through 2025, but the 2.5 mg dose is likely to remain tight due to:

  • Its role as the universal starting dose

  • The massive number of new patients entering treatment

  • Unpredictable supply chain delays

Most health professionals predict the shortage will:

  • Ease gradually in mid–late 2025

  • Normalize by early 2026

However, temporary backorders are expected to continue.

4. What to Do If Your Pharmacy Is Out of Stock

Patients still have multiple options to obtain their medication safely and legally.

4.1. Call Multiple Pharmacies

Do not rely on a single pharmacy. Many patients succeed by calling:

  • Smaller independent pharmacies

  • Hospital pharmacies

  • Specialty diabetes pharmacies

Keep a list of local pharmacies and check weekly.

4.2. Ask Pharmacists to Check Nearby Locations

Most chains can check nearby stores’ inventory in minutes.

Request:
“Can you check stock for Mounjaro 2.5 mg in nearby locations?”

Often, you may find availability in another location even when your local store has none.

4.3. Request Your Name to Be Added to a Waitlist

Most pharmacies maintain:

  • Priority refill lists

  • New-start waitlists

If you are a new patient, ask to be notified immediately when a shipment arrives.

4.4. Check Stock Early in the Day

Pharmacies receive shipments early in the morning. Calling before noon increases your chances.

4.5. Ask Your Prescriber for Flexibility

Depending on your location, your doctor may:

  • Send multiple prescriptions to different pharmacies

  • Adjust your start date

  • Extend your current dose schedule if needed

  • Temporarily switch you to another medication

Do not start at a higher dose to skip 2.5 mg — this increases risk of severe side effects.

5. Alternatives If the 2.5 mg Dose Is Unavailable

Patients who cannot find Mounjaro may discuss temporary alternatives with their doctor.

5.1. Zepbound

Zepbound is also tirzepatide, but marketed specifically for weight loss. Some regions report better availability.

5.2. Ozempic (Semaglutide)

A GLP-1 agonist with similar weight-loss and blood-sugar benefits.

5.3. Wegovy

Semaglutide 2.4 mg injection, FDA-approved for obesity, though it also faces shortages at times.

5.4. Trulicity

Another GLP-1 option, though less effective for weight loss.

These are not identical, but are viable options during a temporary shortage.

6. Tips for Preventing Treatment Delays

You can reduce your chances of running out of medication by following these proactive steps:

6.1. Refill Early

Ask for a refill 7–10 days before your next injection.

6.2. Sign Up for Automatic Refill Notifications

Most pharmacies offer:

  • SMS alerts

  • App notifications

  • Email reminders

This increases chances of securing stock before others.

6.3. Ask Your Doctor to Prescribe More Than One Dose Strength

Some insurance plans allow your doctor to issue prescriptions for:

  • 2.5 mg

  • 5 mg

  • 7.5 mg

This helps ensure timely titration once you secure the first dose.

6.4. Avoid Using Compounded Versions Unless Advised

Compounded tirzepatide:

  • May vary in potency

  • May not match FDA-approved safety standards

  • Should ONLY be used when recommended by a healthcare professional

7. What Eli Lilly Is Doing to Resolve the Shortage

Eli Lilly has announced major steps to end global shortages, including:

7.1. Building New Manufacturing Facilities

A multi-billion dollar investment to expand injectable medication production.

7.2. Increasing Pen Assembly Capacity

The injector pen production line is a major bottleneck; Lilly is increasing output.

7.3. Prioritizing Starter Dose Supply

More batches of 2.5 mg are being scheduled as demand increases.

7.4. Improving Global Distribution Systems

This helps reduce regional delays and uneven supply distribution.

8. Patient Experiences During the Shortage

Many patients report experiencing:

8.1. Delay in Starting Therapy

Some wait 2–6 weeks for the 2.5 mg pen.

8.2. Difficulty Maintaining Titration Schedule

Patients often stay longer on their current dose when stock is unavailable.

8.3. Switching Pharmacies Frequently

Some drive 20–50 miles to find a stocked location.

8.4. Using Apps to Track Medication Stock

Platforms like GoodRx or pharmacy apps provide stock alerts in select regions.

9. The Future of Mounjaro Availability

By 2026, experts expect:

  • Stronger supply chains

  • More consistent global availability

  • Less pressure on starter doses

  • Improved patient access

Given its proven effectiveness, demand will continue rising, but manufacturing expansions are expected to keep up.

Conclusion

The Mounjaro 2.5 mg shortage remains a challenge for both new and returning patients in 2025. With high global demand, manufacturing limitations, and distribution delays, the starter dose continues to face intermittent stock issues.

However, by:

  • Contacting multiple pharmacies

  • Requesting waitlist placement

  • Refilling early

  • Staying flexible with pharmacy options

  • Working closely with your healthcare provider

you can significantly increase your chances of securing your medication on time.